Sickle Cell Research

Research

Our sickle cell center offers many different clinical research trials to help improve the lives and find new treatments for those individuals living with sickle cell disease.

Our Team

  • Karen Hawkins :  Sickle Cell Research Program Manager
  • Brandi Day : Research Coordinator
  • Cheryl Alston : Research Coordinator
  • Joannie Hayes : Research Coordinator
  • Jkeonye Moss : Sickle Cell State Coordinator
  • Linda Wozniak : Research Coordinator
     

Clinical Trials
For more information or to see if you are eligible for a clinical trial today contact Karen Hawkins at 843-792-0560

HGB206: Phase I gene therapy and autologous transplant study

STRIDE: A bone marrow transplant study to evaluate outcomes in patients with sickle cell disease undergoing bone marrow transplant compared to standard of care

Calypso: A Phase II Study to Evaluate Treatment Compliance, Efficacy and Safety of an improved Deferasirox Formulation (granules) in Pediatric Patients with Iron Overload.

STAR- A: Multi-Center Retrospective Registry of Children with Sickle Cell Disease following Hematopoietic Cell Transplantation: A sickle Transplant Alliance for Research (STAR) Project. 

Advocacy & Outreach

The Comprehensive Sickle Cell Center at MUSC Children's Health is working closely with our local foundations and national organizations to raise awareness and advocacy for sickle cell disease as well as to improve funding for this underserved condition.

Partners: